Skip to content

Bakkt BKKT Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

Limbach Holdings, Inc. logo
Limbach Holdings, Inc.LMB
$149K-65.1%
CareDx logo
CareDxCDNA
$0-100%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$0+100%
Commvault Systems logo
Commvault SystemsCVLT
$0
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$95M+1,277%
IAR
Integra LifeSciencesIART
-$1.29M-698%

Other financials

Income statement

See full
Revenue$577.9M+13.3%
Operating income-$16.9M-9.6%
Net income-$11.7M-251%
EPS (diluted)-$0.41-136%

Balance sheet

See full
Cash & equivalents$80.0M+248%
Total debt$79.0K
Total equity$170.9M+288%
Total assets$213.4M+21.0%

Cash flow

See full
Operating cash flow-$12.1M+88.1%
CapEx$19.0K-95.9%
Free cash flow-$101.4M-377%

Valuation

See full
Market cap$350.06M+286%
Enterprise value$270.15M
P/S0.1×-0.2×

Profitability

See full
Operating margin-1.9%-0.8pp
Net margin-0.8%-0.3pp
FCF margin-3.4%

Returns & leverage

See full
Return on equity-117.8%+1,634pp
Debt / equity
Current ratio4.1×+2.5×

Where this comes from

Reported directly by Bakkt in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Bakkt ’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bakkt 's change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bakkt 's change in fair value of contingent consideration?
Bakkt (BKKT) reported change in fair value of contingent consideration of $0 in Q4 2025.
What does change in fair value of contingent consideration mean?
Represents the non-cash adjustment to the fair value of liabilities related to acquisition-based earn-outs or contingent payments. Fluctuations in this value reflect changes in the probability or timing of achieving performance milestones defined in purchase agreements. This metric is critical for assessing the impact of acquisition-related accounting estimates on net income.